{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:44:27Z","timestamp":1790214267080,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["5U01EB012487-00"],"award-info":[{"award-number":["5U01EB012487-00"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2241-2011"],"award-info":[{"award-number":["2241-2011"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.thromres.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:07:11Z","timestamp":1512518831000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support"],"prefix":"10.1016","volume":"163","author":[{"given":"Lorenzo","family":"Valerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0739","authenticated-orcid":false,"given":"Jawaad","family":"Sheriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phat L.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Brengle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Redaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco B.","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Bluestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-6691","authenticated-orcid":false,"given":"Marvin J.","family":"Slepian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.thromres.2017.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.thromres.2017.12.001_bb0010","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J. Heart Lung Transplant."},{"issue":"4 Suppl","key":"10.1016\/j.thromres.2017.12.001_bb0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced heart failure","volume":"29","author":"Slaughter","year":"2010","journal-title":"J. Heart Lung Transplant."},{"issue":"12","key":"10.1016\/j.thromres.2017.12.001_bb0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2015.10.024","article-title":"Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry","volume":"34","author":"Kirklin","year":"2015","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.thromres.2017.12.001_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jtcvs.2003.11.059","article-title":"Platelet activation and aggregation profile in prolonged external ventricular support","volume":"128","author":"Houel","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2017.12.001_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiomech.2016.11.016","article-title":"Shear-mediated platelet activation in the free flow: perspectives on the emerging spectrum of cell mechanobiological mechanisms mediating cardiovascular implant thrombosis","volume":"50","author":"Slepian","year":"2017","journal-title":"J. Biomech."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1345\/aph.1P459","article-title":"Pharmacotherapy for mechanical circulatory support: a comprehensive review","volume":"45","author":"Ensor","year":"2011","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAT.0000000000000500","article-title":"Mechanical circulatory support and antithrombotic therapy: looking for the holy grail","volume":"63","author":"Massicotte","year":"2017","journal-title":"ASAIO J."},{"issue":"2","key":"10.1016\/j.thromres.2017.12.001_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/icvts\/ivs297","article-title":"What is the optimal anticoagulation in patients with a left ventricular assist device?","volume":"15","author":"Rossi","year":"2012","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2017.12.001_bb0060","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAT.0000000000000274","article-title":"Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: an international survey","volume":"62","author":"Jennings","year":"2016","journal-title":"ASAIO J."},{"issue":"13","key":"10.1016\/j.thromres.2017.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2146\/ajhp140538","article-title":"Medication management for left ventricular assist device thrombosis","volume":"72","author":"Hohner","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti-platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0897190015615894","article-title":"Device-related thrombosis in continuous-flow left ventricular assist device support","volume":"29","author":"Doligalski","year":"2016","journal-title":"J. Pharm. Pract."},{"issue":"8","key":"10.1016\/j.thromres.2017.12.001_bb0085","first-page":"532","article-title":"Effect of pentoxifylline on platelet aggregation","volume":"2","author":"Nenci","year":"1981","journal-title":"Pharmatherapeutica"},{"issue":"8","key":"10.1016\/j.thromres.2017.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.112.300570","article-title":"Integrin alphaIIbbeta3: from discovery to efficacious therapeutic target","volume":"112","author":"Bledzka","year":"2013","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0095","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1161\/CIRCHEARTFAILURE.112.966804","article-title":"Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis","volume":"5","author":"Al-Quthami","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MAT.0000000000000028","article-title":"Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb\/IIIa inhibitors?","volume":"60","author":"Bellumkonda","year":"2014","journal-title":"ASAIO J."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.healun.2013.11.002","article-title":"The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices","volume":"33","author":"Tellor","year":"2014","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.healun.2013.07.013","article-title":"Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support","volume":"33","author":"Shah","year":"2014","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2017.12.001_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2016.01.026","article-title":"Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices","volume":"140","author":"Valerio","year":"2016","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-013-0997-6","article-title":"Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device","volume":"37","author":"Sheriff","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0130","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1111\/j.1525-1594.2011.01416.x","article-title":"Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device","volume":"36","author":"Selgrade","year":"2012","journal-title":"Artif. Organs"},{"issue":"3","key":"10.1016\/j.thromres.2017.12.001_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032463","article-title":"Device thrombogenicity emulation: a novel method for optimizing mechanical circulatory support device thromboresistance","volume":"7","author":"Girdhar","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.thromres.2017.12.001_bb0140","doi-asserted-by":"crossref","DOI":"10.1115\/1.4007092","article-title":"A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index","volume":"134","author":"Fraser","year":"2012","journal-title":"J. Biomech. Eng."},{"issue":"2","key":"10.1016\/j.thromres.2017.12.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1115\/1.4026254","article-title":"Thromboresistance comparison of the HeartMate II ventricular assist device with the device thrombogenicity emulation-optimized HeartAssist 5 VAD","volume":"136","author":"Chiu","year":"2014","journal-title":"J. Biomech. Eng."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-015-0364-3","article-title":"Clinical efficacy and safety of cilostazol: a critical review of the literature","volume":"75","author":"Rogers","year":"2015","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0155","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s10439-010-9936-2","article-title":"High-shear stress sensitizes platelets to subsequent low-shear conditions","volume":"38","author":"Sheriff","year":"2010","journal-title":"Ann. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000093104","article-title":"The extent of platelet activation under shear depends on platelet count: differential expression of anionic phospholipid and factor Va","volume":"34","author":"Schulz-Heik","year":"2005","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"5","key":"10.1016\/j.thromres.2017.12.001_bb0165","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood.V72.5.1761.1761","article-title":"A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X","volume":"72","author":"Neuenschwander","year":"1988","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MAT.0b013e31815d6898","article-title":"Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements","volume":"54","author":"Nobili","year":"2008","journal-title":"ASAIO J."},{"issue":"12","key":"10.1016\/j.thromres.2017.12.001_bb0175","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.jbiomech.2010.04.020","article-title":"Device Thrombogenicity Emulator (DTE)\u2014design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs","volume":"43","author":"Xenos","year":"2010","journal-title":"J. Biomech."},{"issue":"5","key":"10.1016\/j.thromres.2017.12.001_bb0180","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"Kroll","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/abio.1999.4148","article-title":"Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin","volume":"272","author":"Jesty","year":"1999","journal-title":"Anal. Biochem."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2017.12.001_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000083845","article-title":"Virchow's triad revisited: abnormal flow","volume":"33","author":"Lowe","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"24","key":"10.1016\/j.thromres.2017.12.001_bb0195","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1161\/CIRCULATIONAHA.111.040246","article-title":"Bleeding and thrombosis in patients with continuous-flow ventricular assist devices","volume":"125","author":"Eckman","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"25","key":"10.1016\/j.thromres.2017.12.001_bb0210","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2017.12.001_bb0215","first-page":"450","article-title":"Pump thrombosis\u2014a riddle wrapped in a mystery inside an enigma","volume":"3","author":"Blitz","year":"2014","journal-title":"Ann. Cardiothorac. Surg."},{"issue":"25","key":"10.1016\/j.thromres.2017.12.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(97)00986-7","article-title":"Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo","volume":"61","author":"Minami","year":"1997","journal-title":"Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.thromres.2017.12.001_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2012.07.001","article-title":"Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity","volume":"691","author":"Yagi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0230","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/VHRM.S3160","article-title":"Safety and efficacy of cilostazol in the management of intermittent claudication","volume":"4","author":"Chi","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2017.12.001_bb0235","author":"FDA"},{"issue":"10","key":"10.1016\/j.thromres.2017.12.001_bb0240","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.thromres.2017.12.001_bb0245","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2017.12.001_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","article-title":"Antiplatelet therapies for the treatment of cardiovascular disease","volume":"9","author":"Michelson","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1039\/b919728a","article-title":"P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions","volume":"2","author":"Maloney","year":"2010","journal-title":"Integr. Biol. (Camb.)"},{"issue":"3","key":"10.1016\/j.thromres.2017.12.001_bb0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1160\/TH07-07-0452","article-title":"Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation","volume":"99","author":"Straub","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0265","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10439-015-1383-7","article-title":"Dielectrophoresis-mediated electrodeformation as a means of determining individual platelet stiffness","volume":"44","author":"Leung","year":"2016","journal-title":"Ann. Biomed. Eng."},{"issue":"1 Supplement","key":"10.1016\/j.thromres.2017.12.001_bb0270","article-title":"Desensitization of DMSO-treated platelets to common agonists via membrane modulation (598.5)","volume":"28","author":"Yamaguchi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.thromres.2017.12.001_bb0275","first-page":"266","article-title":"Modulation of platelet membrane function via exogenous lipid moiety exposure alters platelet responsiveness to shear","volume":"2015","author":"Leung","year":"2015","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0280","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/aor.12602","article-title":"Repetitive hypershear activates and sensitizes platelets in a dose-dependent manner","volume":"40","author":"Sheriff","year":"2016","journal-title":"Artif. Organs"},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0285","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1038\/s41598-017-05130-5","article-title":"High frequency components of hemodynamic shear stress profiles are a major determinant of shear-mediated platelet activation in therapeutic blood recirculating devices","volume":"7","author":"Consolo","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1538-7836.2003.00020.x","article-title":"The assembly of the factor X-activating complex on activated human platelets","volume":"1","author":"Ahmad","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"16","key":"10.1016\/j.thromres.2017.12.001_bb0295","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2013-06-511733","article-title":"Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis","volume":"122","author":"Lechtenberg","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0300","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10439-013-0758-x","article-title":"Evaluation of shear-induced platelet activation models under constant and dynamic shear stress loading conditions relevant to devices","volume":"41","author":"Sheriff","year":"2013","journal-title":"Ann. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0305","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/jth.12566","article-title":"Amplification of human platelet activation by surface pannexin-1 channels","volume":"12","author":"Taylor","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.devcel.2005.12.006","article-title":"Mechanisms of mechanotransduction","volume":"10","author":"Orr","year":"2006","journal-title":"Dev. Cell"},{"issue":"12","key":"10.1016\/j.thromres.2017.12.001_bb0315","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm3896","article-title":"Mechanotransduction and extracellular matrix homeostasis","volume":"15","author":"Humphrey","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.thromres.2017.12.001_bb0320","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0267659115615206","article-title":"Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices","volume":"31","author":"Tran","year":"2016","journal-title":"Perfusion"},{"issue":"4","key":"10.1016\/j.thromres.2017.12.001_bb0325","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2016.06.112","article-title":"Left ventricular assist device design reduces von Willebrand factor degradation: a comparative study between the HeartMate II and the EVAHEART left ventricular assist system","volume":"103","author":"Bartoli","year":"2017","journal-title":"Ann. Thorac. Surg."},{"issue":"6","key":"10.1016\/j.thromres.2017.12.001_bb0330","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jtcvs.2016.01.031","article-title":"Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation","volume":"151","author":"Kang","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2017.12.001_bb0335","author":"NIBIB"},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0340","first-page":"72","article-title":"New insights into the role of erythrocytes in thrombus formation","volume":"40","author":"Du","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.thromres.2017.12.001_bb0345","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/jth.12422","article-title":"Mechanisms of hemolysis-associated platelet activation","volume":"11","author":"Helms","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2017.12.001_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MAT.0b013e3181fcbd86","article-title":"Thrombogenic potential of Innovia polymer valves versus Carpentier-Edwards Perimount Magna aortic bioprosthetic valves","volume":"57","author":"Claiborne","year":"2011","journal-title":"ASAIO J."},{"issue":"3","key":"10.1016\/j.thromres.2017.12.001_bb0355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/0953710031000092839","article-title":"Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time","volume":"14","author":"Jesty","year":"2003","journal-title":"Platelets"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481730587X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481730587X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:37:59Z","timestamp":1758735479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481730587X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":71,"alternative-id":["S004938481730587X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.12.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}